Literature DB >> 9930280

Alternative therapies in exudative age related macular degeneration.

N H Chong1, A C Bird.   

Abstract

Mesh：

Year:  1998        PMID： 9930280      PMCID： PMC1722438          DOI： 10.1136/bjo.82.12.1441

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  32 in total

1.  Surgical excision of subfoveal neovascular membranes in age-related macular degeneration.

Authors:  H M Lambert; A Capone; T M Aaberg; P Sternberg; B A Mandell; P F Lopez
Journal:  Am J Ophthalmol       Date:  1992-03-15       Impact factor: 5.258

2.  Radiation retinopathy--clinical, histopathological, ultrastructural and experimental correlations.

Authors:  D B Archer; W M Amoaku; T A Gardiner
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

3.  Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1994-09-15       Impact factor: 5.258

4.  Do we need a retinal pigment epithelium (or choroid) for the maintenance of retinal apposition?

Authors:  W S Foulds
Journal:  Br J Ophthalmol       Date:  1985-04       Impact factor: 4.638

5.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Authors:  L P Aiello; E A Pierce; E D Foley; H Takagi; H Chen; L Riddle; N Ferrara; G L King; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  Thalidomide is an inhibitor of angiogenesis.

Authors:  R J D'Amato; M S Loughnan; E Flynn; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization.

Authors:  P V Algvere; L Berglin; P Gouras; Y Sheng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-12       Impact factor: 3.117

8.  Definition of two angiogenic pathways by distinct alpha v integrins.

Authors:  M Friedlander; P C Brooks; R W Shaffer; C M Kincaid; J A Varner; D A Cheresh
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

9.  Visual results after surgical removal of subfoveal choroidal neovascular membranes.

Authors:  M A Thomas; J D Dickinson; N S Melberg; H E Ibanez; R S Dhaliwal
Journal:  Ophthalmology       Date:  1994-08       Impact factor: 12.079

10.  Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model.

Authors:  A M Richter; E Waterfield; A K Jain; B Allison; E D Sternberg; D Dolphin; J G Levy
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640
View more
  6 in total

1.  Ophthalmology in the post-genomic era.

Authors:  G C Black; M E Boulton; P N Bishop; D McLeod
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

Review 2.  Age-related macular degeneration: cost-of-illness issues.

Authors:  C Oneill; J Jamison; D McCulloch; D Smith
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial.

Authors:  B C Reeves; R A Harper; W B Russell
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

4.  Analysis of retinal pigment epithelium integrin expression and adhesion to aged submacular human Bruch's membrane.

Authors:  Marco A Zarbin
Journal:  Trans Am Ophthalmol Soc       Date:  2003

5.  Low vision services for vision rehabilitation in the United Kingdom.

Authors:  L E Culham; B Ryan; A J Jackson; A R Hill; B Jones; C Miles; J A Young; C Bunce; A C Bird
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

6.  Reduction of experimental laser-induced choroidal neovascularization by orally administered BPHA, a selective metalloproteinase inhibitor.

Authors:  Takashi Kohri; Mitsuyasu Moriwaki; Masatoshi Nakajima; Hitoshi Tabuchi; Kunihiko Shiraki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-28       Impact factor: 3.117
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.